Complete Up To Date Information about Baytril Antibacterial Tablets.
NADA Number: 140-441 | |
| Proprietary Name |
Baytril® Antibacterial Tablets Baytril® Taste Tabs™ Antibacterial Tablets |
|---|---|
| Sponsor |
Bayer Healthcare LLC, Animal Health Division |
| Sponsor Address |
P. O. Box 390 Sahwnee Mission, KS 66201 USA |
| Ingredients |
Enrofloxacin |
| Species |
Cat, no use class stated or implied Dog, no use class stated or implied |
| Routes of Administration |
Per Os |
| Dose Form |
Tablet |
| Drug Form |
Tablet |
| Dispensing Status |
RX |
| Patent Number |
4670444 |
| Exclusivity |
This Rx supplemental approval is for the treatment of the following bacterial infections in cats: dermal infections (wounds and abscesses) caused by susceptible strains of Pasteurella multocida, Staphylococcus aureus and Staphylococcus epidermidis. The product is approved in tablet form in concentrations of 5.7, 22.7, and 68.0
mg/tablet. This supplemental approval provides for the removal of the contraindication against use in breeding female dogs. The product is Rx and provided at concentrations of 5.7, 22.7, and 68.0 mg/tablet. |
|
Dosage Amount, Indications & Limitations |
520.812 Enrofloxacin tablets. Specifications: Each tablet contains either 22.7, 68.0, or 136 milligrams of enrofloxacin. Conditions of use: Dogs Amount: 5 to 20 milligrams per kilogram (2.27 to 9.07 milligrams per pound) of body weight. Indications: For management of diseases associated with bacteria susceptible to enrofloxacin. Limitations: Administer orally as a single dose or divided into 2 equal doses at 12 hour intervals, daily. Treatment should be continued for 2 to 3 days beyond cessation of clinical symptoms, for a maximum of 30 days for both dogs and cats. Safe use in breeding female cats has not been established. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Cats Amount: 5 to 20 milligrams per kilogram (2.27 to 9.07 milligrams per pound) of body weight. Indications: For management of diseases associated with bacteria susceptible to enrofloxacin. Limitations: Administer orally as a single dose or divided into 2 equal doses at 12 hour intervals, daily. Treatment should be continued for 2 to 3 days beyond cessation of clinical symptoms, for a maximum of 30 days for both dogs and cats. Safe use in breeding female cats has not been established. Federal law restricts this drug to use by or on the order of a licensed veterinarian. |
| Tolerances |
A tolerance of 0.1 part per million for desethylene ciprofloxacin (marker residue) has been established in liver (target tissue) of cattle . |